Annabelle Lim Email & Phone Number

Singapore

Singapore

 Manage and negotiate contractual agreements including non-disclosure agreements, research collaboration agreements, service agreements and material transfer agreements. Engagements with public sector and industry partners on collaborations and platform service provision.  Project life management of institute-wide and multi-party grants, collaboration and services preparation and review of meeting minutes, presentation decks, reports and reviewing of budget and deliverables with team at milestones.  Review of IP assets for timely patent filing before publication deadlines and provision of recommendation to scientists based on patentability criteria of their invention. Coordination and management of ISO 9001:2015 certification process of SIgN platforms. Support in institute-wide IRB as consent taker and industry-related IRBs including advertising the approved IRB study, recruitment of participants, conduct consent taking, coordinating participants' return visits and coordinating the work process between researcher, phlebotomists and study participants.

 Manage and negotiate contractual agreements including non-disclosure agreements, research collaboration agreements, service agreements and material transfer agreements. Engagements with public sector and industry partners on collaborations and platform service provision.  Project life management of institute-wide and multi-party grants, collaboration and services preparation and review of meeting minutes, presentation decks, reports and reviewing of budget and deliverables with team at milestones.  Review of IP assets for timely patent filing before publication deadlines and provision of recommendation to scientists based on patentability criteria of their invention. Coordination and management of ISO 9001:2015 certification process of SIgN platforms. Support in institute-wide IRB as consent taker and industry-related IRBs including advertising the approved IRB study, recruitment of participants, conduct consent taking, coordinating participants' return visits and coordinating the work process between researcher, phlebotomists and study participants.

 Conduct prior art searches in view of patent applications for assessment of patentability and to communicate the decisions for refusal/grant to patent applicants and agents through written opinions and reports.  Knowledge in Singapore patent regulation to scientific inventions and United States, European and Japan patent eligibility criteria.  Field of expertise in patent examination resides in nutraceutical, food, healthcare, pharmaceutical and biotechnological inventions such as personal protective wear e.g. filtered masks, formulations of pharmaceutical compositions, latest T-cell and antibody technology for cancer therapy and infectious diseases, recombinant vaccine technology using bacteria and viruses as delivery vectors, infant and adult milk formulations, disease diagnosis and prognosis methods. Experience in micro- and macro-level analysis of patents and engagement with stakeholders to provide them with insights on actionable intelligence based on patent data and current news.

 Primary research focuses in the exploration of new vaccine carriers in Bordetella pertussis for development of a dengue- and malaria- vaccine.  Involved in the collaboration with principal investigators in Department of Microbiology, NUS and clinicians in National University Hospital, Singapore on preclinical studies of potential therapeutic treatments for dengue infections in mouse models. Training of 2 graduate students from collaborating labs in Singapore Immunology Network (SIgN), ASTAR and Department of Physiology, NUS, on animal work and genetic manipulation of Bordetella pertussis as a vaccine delivery system. Experience in animal husbandry, drafting of NUS Institutional Animal Care and Use Committee (IACUC) protocols and maintenance of annual IACUC reports in the lab.

 Primary research focuses in development of an adenylated cyclase toxin-deleted Bordetella pertussis for evaluation of its preclinical effects on B. pertussis-induced protection and the exploration of the cross- protective effects of live attenuated Bordetella pertussis in influenza and allergy mouse models in collaboration with Institute Pasteur of Lille.  Obtained the Merlion Program Grant, a joint French-Singaporean collaboration to fund travels between the 2 institutes for facilitation of data sharing.  Assisted in the writing of grant proposals wherein a start-up grant was obtained for the project on development of an adenylated cyclase toxin-deleted Bordetella pertussis for evaluation of its effects on B. pertussis-induced protection under the sponsorship of National Medical Research Council (NMRC). Project life cycle management of the awarded grant including preparation of annual reports documenting the budgeting, milestones, key findings and future directions to NMRC.  Training of 2 graduate students from collaborating labs in Singapore Immunology Network (SIgN), ASTAR and Department of Physiology, NUS, on animal work and genetic manipulation of Bordetella pertussis as a vaccine delivery system. Experience in animal husbandry, drafting of NUS Institutional Animal Care and Use Committee (IACUC) protocols and maintenance of annual IACUC reports in the lab. Drafting of SOPs and risk assessments for handling BSL2 bacterial pathogens and tissue organs extracted from infected animals in the programme.

Doctor Of Philosophy, Microbiology, General

B.S. Second Class Honours (Upper), Life Sciences (Concentration In Biomedical Science)